Immunogen | IMGN - Należności Handlowe



Należności Handlowe Zmiana Data
AbbVie USD 12.48B 110M 2026-03
Agios Pharmaceuticals USD 16.13M 5.56M 2026-03
Amgen USD 10.23B 1.09B 2026-06
Astellas Pharma JPY 844.8B 83.04B 2026-06
AstraZeneca USD 18.86B 972M 2026-06
Bristol-Myers Squibb USD 13.83B 535M 2026-06
Eli Lilly USD 23.48B 2.3B 2026-06
Emergent BioSolutions USD 290.1M 134.2M 2023-06
Exelixis USD 322.21M 6.73M 2026-06
Halozyme Therapeutics USD 453.33M 4.66M 2026-06
Heron Therapeutics USD 89.59M 8.54M 2025-12
Intrexon USD 1.02M 559K 2024-06
Karyopharm Therapeutics USD 23.36M 2.82M 2026-03
MacroGenics USD 10.42M 2.95M 2026-03
Nektar Therapeutics USD 3.6M 1.82M 2026-03
Novartis USD 9.6B 2.69B 2026-03
Pfizer USD 16.19B 19M 2026-06
Regeneron Pharmaceuticals USD 6.57B 834.4M 2026-06
Roche Holding CHF 13.34B 1.44B 2026-06
Sanofi EUR 482M 85M 2026-03